Description
Weight loss and diet management is a challenge for millions of people around the world. Globally, more than 1 billion people are above an ideal weight. The affects weight has on life-threatening or life-altering disease are devastating. Diseases such as diabetes, heart disease, and cancer all have links to being overweight or obese.
Increasing education efforts, accessible weight management plans and foods, and a growing desire to be physically desirable have fueled this market in more recent years. More than 100 million people in the United States are actively involved in a weight loss or weight management plan at any one time throughout the year. This suggests a demand for products and services which will continue for years to come.
This Kalorama Information report – Obesity, Weight Loss and Diet Management Markets – focuses on five key segments of products, treatments, and services:
- Diet Foods and Drinks (Drinks and powders, Bars and Snacks, Meals, Desserts)
- Weight Loss Drugs (Prescription Drugs, OTC)
- Natural Therapies for Weight Loss
- Surgical Interventions (Gastric Banding, Other)
- Weight Loss Programs (Revenues from Delivered Food, Revenues From Program Fees)
The report includes statistical information for obesity and higher body mass worldwide, with special emphasis on the U.S. and Europe. The market segments provide an overview, description of products on the market, market estimates and forecasts, and trends in the industry. Trends discussed in the report include:
- Weight Loss Incentives in the Work Environment
- Healthy Lifestyle and American Cancer Society
- Outlook for a Healthier U.S. Population
- Childhood Obesity
- Inadequate Levels of Sleep, Technology, Caffeine, and the Affect on Adolescents
- Weight Loss Camps and Schools
- Factors that Affect Weight Among Adolescent Girls
- ‘Smart Choices Program’
- New Developments in Pharmaceutical Weight Loss
- New Developments in Weight Loss Surgical Devices
- Trends in Bariatric Surgery
- Obesity Trends During Socioeconomic Changes
- Discontinued Weight Loss Drugs
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering primary information.
For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue data presented in this report.
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2009. Historical data was provided for the years 2006 through 2008, with forecast data provided for 2010 through 2013. Compound annual growth rates (CAGRs) are provided for the 2006-2009, 2009-2013 and 2006-2013 periods for each segment covered.
The forecasted market analysis for 2010-2013 was based on probability of drug approval and sales of products in late stage development, future trends in current product demand, obesity statistics and trends, product marketing, and relevant demographic trends.
Table of Contents
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Overview
- Scope and Methodology
- Defining Obesity
- Size and Growth of the Market
- Trends Affecting the Market
- Leading Competitors
CHAPTER TWO: INTRODUCTION
- Overview of the Industry
- Industry Definitions
- Weight Management
- Statistics and Trends in Weight
- Global Obesity Statistics
- Indicators and Causes of Weight Gain
- Genetics
- Environmental
- Socioeconomic
- Lifestyle Changes Promoting Weight Gain
- Changes in Physical Activity in the United States
- Changes in Food Consumption in the United States
- Nutrition Analysis
- Carbohydrates
- Proteins
- Fats
- Vitamins
- Minerals
- Complications of Excessive Weight Gain
- Diabetes
- Gallbladder Disease
- Heart Disease and Stroke
- Hypertension
- Osteoarthritis
- Sleep Apnea
- Cancer
- World Demographics
CHAPTER THREE: MARKET SEGMENTS
- Overview
- Diet Foods and Drinks
- Diet Drinks and Powders
- Diet Bars
- Low Fat/ Low Calorie Frozen and Convenient Meals
- Diet Desserts—Puddings, Ice Cream and Cookies
- Drug Therapy
- Prescription Pharmaceuticals
- Over-the-Counter Pharmaceuticals
- Natural Therapy
- Surgical Interventions
- Restrictive Surgery
- Combined Restrictive and Malabsorptive Surgery
- Weight Loss Programs
CHAPTER FOUR: MARKET ANALYSIS
- Summary
- Weight Loss and Diet Management Market by Product Segment
- Diet Foods and Drinks
- Weight Loss Drugs
- Natural Therapies for Weight Loss
- Surgical Interventions
- Weight Loss Programs
- Weight Loss and Diet Management Market by Geographical Region
CHAPTER FIVE: MARKET TRENDS
- Overview
- Weight Loss Incentives in the Work Environment
- Healthy Lifestyle and the American Cancer Society
- Outlook for a Healthier US Population
- Childhood Obesity
- European Childhood Obesity Surveillance
- United States Childhood Obesity Surveillance
- Inadequate Levels of Sleep, Technology, Caffeine, and the Effect on Adolescents
- Weight Loss Camps and Schools
- Weight Loss Destinations
- Wellspring Camps
- Green Mountain at Fox Run
- Camp Shane
- Camp La Jolla
- Weight Loss Schools
- Wellspring Academies
- Factors that Affect Weight Among Adolescent Girls
- Healthy Options in Fast Food and Fast-Casual Restaurants
- ‘Smart Choices’ Program
- New Developments in Pharmaceutical Weight Loss
- New Developments in Weight Loss Surgical Devices
- Trends in Bariatric Surgery
- Obesity Trends During Socioeconomic Changes
- Discontinued Weight Loss Drugs
CHAPTER SIX: COMPANY PROFILES
- Overview
- Abbott Laboratories
- GlaxoSmithKline
- Hormel
- Kellogg
- Medifast
- Nestlé Nutrition
- NutriSystem
- Pharmavite
- Roche
- Unilever
- Weight Watchers
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: The World Market for Weight Loss and Diet Management Treatments 2006-2013
- Figure 1-1: The World Market for Weight Loss and Diet Management Treatments 2006-2013
CHAPTER TWO: INTRODUCTION
- Table 2-1: Body Mass Index (BMI) Chart
- Table 2-2: Estimated Obesity by Country 2009 Estimates
- Figure 2-1: Estimated Obesity by Country as a Portion of Total Population 2009 Estimates
- Figure 2-2: Increases in Obesity by Country—2007 and 2009 Figures
- Table 2-3: Broad Indicators/Causes of Weight Gain
- Figure 2-3: U.S. Percentage of Adults Engaging in Leisure-Time, Transportation-Related and Household-Related Physical Activity, Estimated 2009
- Table 2-4: Impact of Modernization on Obesity
- Figure 2-4: U.S. Civilian Consumption of Food Calories per day, 1970 to 2010
- Figure 2-5: U.S. Civilian Consumption of Food Nutrients per day, 1970 to 2010
- Figure 2-6: U.S. Civilian Consumption of Major Food Commodities, Per Capita, 1980 to 2010
- Figure 2-7: U.S. Civilian Consumption of Selected Beverages, Per Capita, 1980 to 2010
- Table 2-5: Essential Nutrients for Human Health
- Table 2-6: Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Type 2 Diabetes
- Table 2-7: Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Cancer
- Table 2-8: Estimated World Population by Age and Geographical Region, 2009
- Figure 2-8: Estimated World Population by Age and Geographical Region, 2009
- Table 2-9: World Population by Selected Geographical Region, 2010 – 2050
- Figure 2-9: World Population by Selected Geographical Region, 2007-2050
CHAPTER THREE: MARKET SEGMENTS
- Table 3-1: FDA Delimitations of Nutrient Content Claims for Fat and Calories
- Table 3-2: Diet Drinks and Powders—Examples*
- Table 3-3: Diet Bars—Examples*
- Table 3-4: Low Fat/Low Calorie Frozen and Convenient Meals—Examples*
- Table 3-5: Diet Desserts—Examples*
- Table 3-6: Selected Bariatric Surgery Devices, by Company
- Table 3-7: Popular Weight Loss Program Details
CHAPTER FOUR: MARKET ANALYSIS
- Table 4-1: The World Market for Weight Loss and Diet Management Treatments 2006-2013
- Figure 4-1: The World Market for Weight Loss and Diet Management Treatments 2006-2013
- Table 4-2: Market by Product Segment 2006-2013
- Figure 4-2: Market by Product Segment 2006-2013
- Figure 4-3: Market by Product Segment 2009 and 2013
- Table 4-3:Diet Food and Drink Market by Product Type 2006-2013
- Figure 4-4: Diet Food and Drink Market by Product Type 2006-2013
- Figure 4-5: Diet Food and Drink Market by Product Type 2009 and 2013
- Table 4-4: Weight Loss Drug Market by Product Type (Prescription, OTC) 2006-2013
- Figure 4-6: Weight Loss Drug Market by Product Type (Prescription, OTC) 2006-2013
- Figure 4-7: Weight Loss Drug Market by Product Type 2009 and 2013
- Table 4-5: Natural Therapies for Weight Loss Market 2006-2013
- Figure 4-8: Natural Therapies for Weight Loss Market 2006-2013
- Table 4-6: Weight Loss Devices Used in Surgical Intervention: Market by Product Segment (Gastric Bypass, Others) 2006-2013
- Figure 4-9: Weight Loss Devices Used in Surgical Intervention: Market by Product Segment (Gastric Bypass, Others) 2006-2013
- Figure 4-10: Weight Loss Devices Used in Surgical Intervention: Market by Product Segment (Gastric Bypass, Others) 2009 and 2013
- Table 4-7: Market for Weight Loss and Programs by Product Segment (Delivered Food, Program Revenue) 2006-2013
- Figure 4-11: Market for Weight Loss and Programs and Services by Product Segment 2006-2013
- Figure 4-12: Market for Weight Loss and Programs by Product Segment (Delivered Food, Program Revenue) 2009 and 2013
- Table 4-8: The Weight Loss and Diet Management Market Estimated Sales by Geographic Region 2006-2013
- Figure 4-13: The Weight Loss and Diet Management Market Estimated Sales by Geographic Region 2006-2013
- Figure 4-14: The Weight Loss and Diet Management Market Estimated Sales by Geographic Region 2009 and 2013
CHAPTER FIVE: TRENDS
- Table 5-1: Obesity Rates by State, 2008-2009
- Table 5-2: Estimated Childhood Overweight and Obesity Prevalence by Age Group and Country
- Table 5-3: Prevalence of Obesity in Children and Adolescents
- Table 5-4: Obesity Pharmaceutical Development Pipelines, 2009
- Figure 5-1: Obesity Pharmaceutical Development by Phase, 2009
- Table 5-5: Weight Loss Surgical Devices in Development*
- Table 5-6: U.S. Trends in Bariatric Surgery – Number of Cases by Gender
- Figure 5-2: U.S. Trends in Bariatric Surgery – Number of Cases by Gender
